Float Short %

1.45

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

-0.11

EPS Last/This Y

EPS This/Next Y

0.46

Price

88.49

Target Price

115

Analyst Recom

1.95

Performance Q

-11.06

Relative Volume

0.91

Beta

1.02

Ticker: COO

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	COO	95.84	0.47	0.63	2428
2025-01-24	COO	97.71	0.47	0.01	2443
2025-01-27	COO	99.47	0.43	0.21	2576
2025-01-28	COO	98.51	0.44	0.00	2561
2025-01-29	COO	98	0.44	0.17	2566
2025-01-30	COO	98.1	0.44	0.10	2567
2025-01-31	COO	96.54	0.44	0.00	2573
2025-02-03	COO	95.37	0.44	1.17	2575
2025-02-04	COO	95.34	0.45	0.33	2583
2025-02-05	COO	96.7	0.44	3.00	2581
2025-02-06	COO	95.26	0.45	0.17	2590
2025-02-07	COO	93.53	0.45	0.00	2592
2025-02-10	COO	93.64	0.45	999.99	2589
2025-02-11	COO	93.39	0.45	0.02	2590
2025-02-12	COO	92.01	0.42	9.18	2713
2025-02-13	COO	93.68	0.94	0.52	3693
2025-02-14	COO	88.1	0.84	1.42	3960
2025-02-18	COO	86.71	0.95	0.20	5243
2025-02-19	COO	86.42	0.58	0.09	8230
2025-02-20	COO	88.67	0.58	0.36	8343
2025-02-21	COO	88.49	0.58	1.23	8720
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	COO	95.68	7.4	66.9	3.98
2025-01-24	COO	97.64	7.4	77.2	3.98
2025-01-27	COO	99.43	7.4	75.3	3.98
2025-01-28	COO	98.52	7.4	57.1	3.98
2025-01-29	COO	98.00	7.4	59.9	3.98
2025-01-30	COO	98.10	7.4	64.1	3.98
2025-01-31	COO	96.49	7.4	52.3	3.98
2025-02-03	COO	95.34	7.4	54.9	3.98
2025-02-04	COO	95.32	7.4	63.2	3.98
2025-02-05	COO	96.63	7.4	73.1	3.98
2025-02-06	COO	95.28	7.4	53.7	3.98
2025-02-07	COO	93.55	7.4	51.1	3.98
2025-02-10	COO	93.63	7.4	63.8	3.98
2025-02-11	COO	93.42	7.4	61.8	3.98
2025-02-12	COO	92.01	7.4	53.0	3.98
2025-02-13	COO	93.67	7.4	75.5	3.98
2025-02-14	COO	88.10	7.4	23.4	3.98
2025-02-18	COO	87.26	7.2	57.0	3.98
2025-02-19	COO	86.46	7.2	57.0	3.98
2025-02-20	COO	88.68	7.2	80.4	3.98
2025-02-21	COO	88.49	7.2	61.8	3.98
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	COO	-18.13	-1.12	1.38
2025-01-24	COO	-18.13	-1.12	1.38
2025-01-27	COO	-18.13	-0.96	1.38
2025-01-28	COO	-18.13	-0.96	1.39
2025-01-29	COO	-18.13	-0.96	1.39
2025-01-30	COO	-18.13	-0.96	1.39
2025-01-31	COO	-18.13	-0.96	1.39
2025-02-03	COO	-18.13	-0.35	1.39
2025-02-04	COO	-17.16	-0.35	1.39
2025-02-05	COO	-17.40	-0.35	1.39
2025-02-06	COO	-17.40	-0.35	1.39
2025-02-07	COO	-17.40	-0.35	1.39
2025-02-10	COO	-17.40	-0.87	1.39
2025-02-11	COO	-11.38	-0.87	1.40
2025-02-12	COO	-11.38	-0.87	1.45
2025-02-13	COO	-16.50	-0.87	1.45
2025-02-14	COO	-16.50	-0.87	1.45
2025-02-18	COO	-16.50	-0.52	1.45
2025-02-19	COO	-16.29	-0.52	1.45
2025-02-20	COO	-16.29	-0.52	1.45
2025-02-21	COO	-16.29	-0.52	1.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.04

Avg. EPS Est. Current Quarter

0.91

Avg. EPS Est. Next Quarter

0.93

Insider Transactions

-16.29

Institutional Transactions

-0.52

Beta

1.02

Average Sales Estimate Current Quarter

981

Average Sales Estimate Next Quarter

1003

Fair Value

109.31

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

23.7

Max Drawdown 5-Year %

-45.4

Target Price

115

P/E

45.24

Forward P/E

19.97

PEG

4.38

P/S

4.54

P/B

2.18

P/Free Cash Flow

61.41

EPS

1.96

Average EPS Est. Cur. Y

3.98

EPS Next Y. (Est.)

4.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.07

Relative Volume

0.91

Return on Equity vs Sector %

-14.4

Return on Equity vs Industry %

-4.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

61.8

The Cooper Companies, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 16000

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

stock quote shares COO – The Cooper Companies, Inc. Stock Price stock today

news today COO – The Cooper Companies, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch COO – The Cooper Companies, Inc. yahoo finance google finance

stock history COO – The Cooper Companies, Inc. invest stock market

stock prices COO premarket after hours

ticker COO fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: COO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y